DM1 is caused by an abnormal expansion of a (CTG)n trinucleotide repeat in the DMPK gene, and downregulation of DMPK mRNA expression represents a potential DM1 therapeutic avenue.38 Here, DMPK is linked to myotonic dystrophy type 1.